levodopa has been researched along with cyclosporine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 8 (47.06) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Avdeef, A; Tam, KY | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Ansari, AA; Breeze, RE; Freed, CR; Hutchinson, M; Kriek, EH; Mayne, A; Mazziotta, JC; O'Brien, CF; Schneck, SA; Zhang, YB | 1 |
| Fernandes, MH; Pestana, M; Pinto-do-O, PC; Soares-da-Silva, P; Vieira-Coelho, MA | 1 |
| Pestana, M; Serrão, MP; Soares-da-Silva, P; Vieira-Coelho, MA | 1 |
| Akamatsu, Y; Fujimori, K; Kawagishi, N; Miyagi, S; Sato, A; Satomi, S; Sekiguchi, S | 1 |
| Defebvre, L; Degardin, A; Dequatre, N; Destée, A; Devos, D; Lacour, A; Lionet, A; Moreau, C | 1 |
| Lima, MA; Maradei, S; Maranhao Filho, P | 1 |
1 trial(s) available for levodopa and cyclosporine
| Article | Year |
|---|---|
Lack of a detectable systemic humoral/cellular allogeneic response in human and nonhuman primate recipients of embryonic mesencephalic allografts for the therapy of Parkinson's disease.
Topics: Animals; Antibody Formation; Antibody-Dependent Cell Cytotoxicity; Brain Tissue Transplantation; Cell Line; Cyclosporine; Cytotoxicity, Immunologic; Fetal Tissue Transplantation; Follow-Up Studies; Humans; Immunity, Cellular; Levodopa; Lymph Nodes; Mesencephalon; Parkinson Disease; Prednisone; Primates; Spleen; T-Lymphocytes, Cytotoxic; Time Factors; Transplantation, Homologous | 1995 |
16 other study(ies) available for levodopa and cyclosporine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Assessment of renal dopaminergic system activity during cyclosporine A administration in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Aromatic-L-Amino-Acid Decarboxylases; Blood Pressure; Catechol O-Methyltransferase; Creatinine; Cyclosporine; Dopamine; Homovanillic Acid; In Vitro Techniques; Injections, Subcutaneous; Kidney Cortex; Kidney Tubules; Levodopa; Male; Monoamine Oxidase; Potassium; Rats; Rats, Wistar; Sodium; Urea | 1995 |
Evidence for the involvement of P-glycoprotein on the extrusion of taken up L-DOPA in cyclosporine A treated LLC-PK1 cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benserazide; Body Water; Calcium Channel Blockers; Cell Survival; Cyclosporine; Decarboxylation; Dopamine; Dopamine Agents; Levodopa; LLC-PK1 Cells; Swine; Verapamil | 1998 |
Parkinsonism during cyclosporine treatment in liver transplantation: an unusual case report.
Topics: Adult; Cyclosporine; Hepatitis C; Humans; Immunosuppressive Agents; Levodopa; Liver Cirrhosis; Liver Transplantation; Male; Parkinsonian Disorders; Treatment Outcome | 2008 |
[West Nile meningoencephalitis in an immunocompromised patient].
Topics: Anti-Inflammatory Agents; Coma; Cyclosporine; Dopamine Agents; Enzyme-Linked Immunosorbent Assay; Fatal Outcome; Humans; Immunocompromised Host; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Kidney Transplantation; Levodopa; Magnetic Resonance Imaging; Male; Meningoencephalitis; Mycophenolic Acid; Prednisolone; Reverse Transcriptase Polymerase Chain Reaction; West Nile Fever; West Nile virus; Young Adult | 2008 |
Cyclosporine-induced parkinsonism.
Topics: Antiparkinson Agents; Brain; Carbidopa; Cyclosporine; Fatal Outcome; Hematoma, Subdural; Humans; Immunosuppressive Agents; Leukemia, Lymphoid; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Parkinsonian Disorders; Stem Cell Transplantation | 2009 |